简体中文

Press releases

14 May 2024

Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress and Published in the New England Journal of Medicine

Read article
08 Apr 2024

Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session

Read article
05 Apr 2024

LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials

Read article
13 Mar 2024

JIXING Announces the CTA Approval of China Cohort of ACACIA-HCM, a Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Read article
08 Mar 2024

The Phase 3 Study Results of Varenicline Solution Nasal Spray for The Treatment of Dry Eye Disease in Chinese Patients Was Published in The Lancet Subset

Read article
19 Feb 2024

JIXING Announces First Subject Successfully Dosed in Australian Phase I Clinical Trial of JX09

Read article
Load more

Developing innovative cardiometabolic therapies globally

Copyright © 2026 CORXEL. All Rights Reserved.
Designed & built by SampsonMay

沪ICP备20017872号-3

沪公网安备31010602008424号